Cision Newshttps://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Wed, 10 Jun 2026 03:43:02 GMTCision News14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pngArexis receives European patent on a novel target for diabetes treatmenthttp://news.cision.com/arexis/r/arexis-receives-european-patent-on-a-novel-target-for-diabetes-treatment,c154520cision112911Wed, 08 Jun 2005 13:00:00 GMTRein Seensalu joins Arexis as Vice President Clinical Science and Developmenthttp://news.cision.com/arexis/r/rein-seensalu-joins-arexis-as-vice-president-clinical-science-and-development,c153157cision112253Mon, 30 May 2005 06:00:00 GMTArexis enters into collaboration with CMC Biopharmaceuticals for the production of BSSL for clinical trialshttp://news.cision.com/arexis/r/arexis-enters-into-collaboration-with-cmc-biopharmaceuticals-for-the-production-of-bssl-for-clinical-trials,c139703cision106575Mon, 07 Mar 2005 11:00:00 GMTArexis’ SCCE project receives VINNOVA granthttp://news.cision.com/arexis/r/arexis--scce-project-receives-vinnova-grant,c137849cision105861Mon, 21 Feb 2005 13:00:00 GMTArexis obtains orphan drug designation in the EU for novel cystic fibrosis therapyhttp://news.cision.com/arexis/r/arexis-obtains-orphan-drug-designation-in-the-eu-for-novel-cystic-fibrosis-therapy,c135475cision104757Tue, 08 Feb 2005 09:00:00 GMTAREXIS PRESENTS SUCCESSFUL PHASE II RESULTS OF NOVEL THERAPY FOR CYSTIC FIBROSIShttp://news.cision.com/arexis/r/arexis-presents-successful-phase-ii-results-of-novel-therapy-for-cystic-fibrosis,c120187cision98573Mon, 18 Oct 2004 08:07:06 GMTArexis in Commercial Collaboration with Beiersdorf around Novel Skin Care Concepthttp://news.cision.com/arexis/r/arexis-in-commercial-collaboration-with-beiersdorf-around-novel-skin-care-concept,c119331cision98292Mon, 11 Oct 2004 08:09:40 GMTAREXIS GETS EU FUNDING FOR A CLINICAL STUDY ON IMPROVED NUTRITION IN PRETERM INFANTShttp://news.cision.com/arexis/r/arexis-gets-eu-funding-for-a-clinical-study-on-improved-nutrition-in-preterm-infants,c117154cision97518Wed, 22 Sep 2004 10:08:38 GMTArexis acquires project in lipid metabolismhttp://news.cision.com/arexis/r/arexis-acquires-project-in-lipid-metabolism,c94846cision87629Tue, 17 Feb 2004 11:00:58 GMTArexis AB has today initiated a phase II clinical study in the area of lipid metabolismhttp://news.cision.com/arexis/r/arexis-ab-has-today-initiated-a-phase-ii-clinical-study-in-the-area-of-lipid-metabolism,c82005cision79125Tue, 08 Jul 2003 13:31:28 GMTSwedish drug discovery company Arexis AB raises SEK 63 millionhttp://news.cision.com/arexis/r/swedish-drug-discovery-company-arexis-ab-raises-sek-63-million,c81700cision78836Tue, 01 Jul 2003 10:49:26 GMTPatent approval for treating common skin disordershttp://news.cision.com/arexis/r/patent-approval-for-treating-common-skin-disorders,c73976cision71430Wed, 12 Feb 2003 09:54:46 GMTGene discovery points to new possibilities for the treatment of rheumatoid arthritishttp://news.cision.com/arexis/r/gene-discovery-points-to-new-possibilities-for-the-treatment-of-rheumatoid-arthritis,c70382cision67902Tue, 03 Dec 2002 09:58:11 GMTArexis announces completion of 48 million SEK private placement.http://news.cision.com/arexis/r/arexis-announces-completion-of-48-million-sek-private-placement-,c43503cision41432Wed, 30 May 2001 11:06:27 GMT